Top Markets
#1 ADO Protocol ADO Protocol +194.54%
#2 Islamic Coin Islamic Coin +155.33%
#3 GoPlus Security GoPlus Security +40.11%
#4 GAIB AID GAIB AID +24.67%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.36%
#6 Wrapped NXM Wrapped NXM +14.17%
#7 Verus Coin Verus Coin +13.65%
#8 Casper Network Casper Network +13.15%
#9 Pons Pons +12.20%
#10 o1.exchange o1.exchange +12.20%
Coin of the day
ADO Protocol ADO Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Rang in Aktien #33736
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Aktienkurs
$4.58
Zuletzt synchronisiert: 2025-05-09
Marktkapitalisierung
$6.98M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
US
Handel NeuroMetrix, Inc. (NURO)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von NeuroMetrix, Inc. (NURO)
Anzahl der ausstehenden Aktien zum December 2024: 2.05M
Laut den neuesten Finanzberichten und dem Aktienkurs von NeuroMetrix, Inc. beträgt die aktuelle Anzahl der ausstehenden Aktien 2.05M. Am Ende von December 2023 hatte das Unternehmen 1.04M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von NeuroMetrix, Inc. (NURO) von 2001 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 2.05M 4.12%
2024 1.97M 89.16%
2023 1.04M 16.84%
2022 891.27K -65.26%
2021 2.57M -32.27%
2020 3.79M 218.80%
2019 1.19M 57.26%
2018 755.47K 344.01%
2017 170.15K 103.32%
2016 83.69K 65.42%
2015 50.59K 98.58%
2014 25.48K 37.13%
2013 18.58K 177.71%
2012 6.69K 233.33%
2011 2.01K 0.45%
2010 2.00K 37.23%
2009 1.46K 22.15%
2008 1.19K 8.76%
2007 1.10K 1.01%
2006 1.09K 2.94%
2005 1.05K 0.96%
2004 1.04K 3.98%
2003 1.00K 0.00%
2002 1.00K 0.00%
2001 1.00K 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 1.74B 84,884.21%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 383.50M 18,597.94%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 1.28B 62,410.12%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 1.48B 71,941.92%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 576.40M 28,002.98%
US